The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00106548 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

NCT00144521 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

NCT01119859 ·Status: COMPLETED ·Phase: PHASE4

Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

NCT01258712 ·Status: COMPLETED ·Phase: PHASE3

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01232569 ·Status: COMPLETED ·Phase: PHASE3

Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT02101307 ·Status: COMPLETED

A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis

NCT00848120 ·Status: COMPLETED ·Phase: PHASE3

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

NCT00144508 ·Status: COMPLETED ·Phase: PHASE3

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

NCT04312815 ·Status: UNKNOWN ·Phase: PHASE3

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

NCT03155347 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT01089023 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT00106574 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis

NCT00109408 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

NCT00106535 ·Status: COMPLETED ·Phase: PHASE3

An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

NCT00750880 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

NCT01034397 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01741688 ·Status: COMPLETED

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

NCT01251120 ·Status: TERMINATED ·Phase: PHASE4

A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

NCT02001987 ·Status: COMPLETED ·Phase: PHASE3

A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

NCT02046616 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01211834 ·Status: COMPLETED ·Phase: PHASE3

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

NCT01661140 ·Status: TERMINATED ·Phase: PHASE4

Study of MRA in Patients With Rheumatoid Arthritis (RA)

NCT00144651 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

NCT00106522 ·Status: COMPLETED ·Phase: PHASE3

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

NCT02011334 ·Status: COMPLETED ·Phase: PHASE3